Healthcare provider profile · identity verified

Jeffrey C Terry, M.D.

Internal Medicine · GAINESVILLE, GA · NPI 1124021761

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	331	80
Atorvastatin Calcium	Atorvastatin Calcium	315	79
Levothyroxine Sodium	Levothyroxine Sodium	242	56
Amlodipine Besylate	Amlodipine Besylate	233	63
Lisinopril	Lisinopril	189	46
Repatha Sureclick	Evolocumab	147	20
Losartan Potassium	Losartan Potassium	138	35
Duloxetine Hcl	Duloxetine Hcl	132	21
Ezetimibe	Ezetimibe	131	27
Prednisone	Prednisone	129	72
Potassium Chloride	Potassium Chloride	124	33
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	112	112
Tamsulosin Hcl	Tamsulosin Hcl	112	26
Omeprazole	Omeprazole	103	30
Metoprolol Succinate	Metoprolol Succinate	98	28
Bupropion Xl	Bupropion Hcl	96	19
Hydrochlorothiazide	Hydrochlorothiazide	90	23
Gabapentin	Gabapentin	89	22
Eliquis	Apixaban	88	19
Citalopram Hbr	Citalopram Hydrobromide	84	21
Esomeprazole Magnesium	Esomeprazole Magnesium	81	19
Sertraline Hcl	Sertraline Hcl	81	17
Finasteride	Finasteride	79	18
Praluent Pen	Alirocumab	75	14
Furosemide	Furosemide	74	22
Linzess	Linaclotide	73	suppressed
Ozempic	Semaglutide	73	11
Zolpidem Tartrate	Zolpidem Tartrate	63	23
Alprazolam	Alprazolam	62	20
Azithromycin	Azithromycin	62	51
Meloxicam	Meloxicam	61	30
Trazodone Hcl	Trazodone Hcl	60	21
Pregabalin	Pregabalin	59	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	45
Mounjaro	Tirzepatide	56	suppressed
Allopurinol	Allopurinol	52	13
Liothyronine Sodium	Liothyronine Sodium	50	suppressed
Simvastatin	Simvastatin	50	13
Montelukast Sodium	Montelukast Sodium	48	12
Ondansetron Hcl	Ondansetron Hcl	46	21
Metoprolol Tartrate	Metoprolol Tartrate	45	11
Metformin Hcl Er	Metformin Hcl	44	suppressed
Metformin Hcl	Metformin Hcl	43	11
Carvedilol	Carvedilol	42	suppressed
Memantine Hcl	Memantine Hcl	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	15
Synthroid	Levothyroxine Sodium	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	13
Fluticasone Propionate	Fluticasone Propionate	36	13
Lorazepam	Lorazepam	36	16
Pantoprazole Sodium	Pantoprazole Sodium	36	11
Valsartan	Valsartan	36	12
Clonazepam	Clonazepam	34	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Repatha Syringe	Evolocumab	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Diazepam	Diazepam	31	suppressed
Famotidine	Famotidine	30	11
Meclizine Hcl	Meclizine Hcl	30	12
Methylprednisolone	Methylprednisolone	29	25
Albuterol Sulfate Hfa	Albuterol Sulfate	28	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	23
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	18
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	11
Ibandronate Sodium	Ibandronate Sodium	25	suppressed
Raloxifene Hcl	Raloxifene Hcl	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	21	suppressed
Atenolol	Atenolol	20	suppressed
Cephalexin	Cephalexin	20	19
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Spironolactone	Spironolactone	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Clonidine	Clonidine	18	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	18	suppressed
Estradiol	Estradiol	18	suppressed
Vascepa	Icosapent Ethyl	18	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Lidocaine Hcl	Lidocaine Hcl	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Cefdinir	Cefdinir	15	15
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Mesalamine	Mesalamine	12	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Estradiol (Once Weekly)	Estradiol	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error